These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22663553)

  • 1. Translational research in oncology: the need of additional in vitro preclinical testing methods for new drugs.
    Drell TL; Zanker KS; Entschladen F
    Curr Pharm Des; 2012; 18(23):3416-20. PubMed ID: 22663553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology.
    Candini O; Grisendi G; Foppiani EM; Brogli M; Aramini B; Masciale V; Spano C; Petrachi T; Veronesi E; Conte P; Mari G; Dominici M
    Sci Rep; 2019 May; 9(1):7154. PubMed ID: 31073193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
    Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
    Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
    Ruggeri BA; Camp F; Miknyoczki S
    Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the unmet medical need: the Abbott Laboratories oncology approach.
    Carlson DM; Steinberg JL; Gordon G
    Clin Adv Hematol Oncol; 2005 Sep; 3(9):703-10. PubMed ID: 16224444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
    Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical imaging and translational animal models of cancer for accelerated clinical implementation of nanotechnologies and macromolecular agents.
    De Souza R; Spence T; Huang H; Allen C
    J Control Release; 2015 Dec; 219():313-330. PubMed ID: 26409122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-metastatics: an overview of drug candidates in current pipelines.
    Schaap-Nutt A; Thyssen DA; Drell DW; Entschladen F
    Curr Pharm Des; 2014; 20(42):6522-8. PubMed ID: 25341929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Derived Xenograft: An Adjuvant Technology for the Treatment of Metastatic Disease.
    Bousquet G; Janin A
    Pathobiology; 2016; 83(4):170-6. PubMed ID: 27010922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical screening methods in cancer.
    Kumar S; Bajaj S; Bodla RB
    Indian J Pharmacol; 2016; 48(5):481-486. PubMed ID: 27721530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking
    Jo Y; Choi N; Kim K; Koo HJ; Choi J; Kim HN
    Theranostics; 2018; 8(19):5259-5275. PubMed ID: 30555545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Potential of Migrastatin-Core Analogs for the Treatment of Metastatic Cancer.
    Giralt E; Lo Re D
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28208778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted approaches to childhood cancer: progress in drug discovery and development.
    Hirsch S; Marshall LV; Carceller Lechon F; Pearson AD; Moreno L
    Expert Opin Drug Discov; 2015 May; 10(5):483-95. PubMed ID: 25840490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
    Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
    Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
    Kawaguchi T; Foster BA; Young J; Takabe K
    J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models.
    HogenEsch H; Nikitin AY
    J Control Release; 2012 Dec; 164(2):183-6. PubMed ID: 22446384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical anticancer activity of the specific endothelin A receptor antagonist ZD4054.
    Growcott JW
    Anticancer Drugs; 2009 Feb; 20(2):83-8. PubMed ID: 19065106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.